ENDEAVOR RX SPRINT CORONARY STENT SYSTEM
Report
- Report Number
- 9612164-2011-00801
- Event Type
- Injury
- Date Received
- July 21, 2011
- Date of Event
- August 14, 2009
- Report Date
- July 7, 2011
- Manufacturer
- MEDTRONIC IRELAND
- Product Code
- NIQ
- PMA / PMN Number
- P060033
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4). EVAL, RESULTS: (MYOCARDIAL INFARCTION & REVASCULARIZATION).
THE PT HAD ONE ENDEAVOR RX DRUG ELUTING STENT IMPLANTED TO THE PROXIMAL LAD. THE NEXT DAY, DURING A PLANNED STAGED PROCEDURE, THE PT HAD ONE ENDEAVOR SPRINT RX DRUG ELUTING STENT IMPLANTED TO THE 1ST OBTUSE MARGINAL. FOLLOWING REVIEW BY THE CLINICAL EVENTS COMMITTEE, IT IS REPORTED THAT A NON Q-WAVE MI OCCURRED ON THE SAME DAY. FOUR DAYS LATER, DURING A PLANNED STAGED PROCEDURE, THE PT HAD ONE ENDEAVOR SPRINT RX DRUG ELUTING STENT IMPLANTED TO THE 1ST LEFT POSTEROLATERAL BRANCH. THE PT WAS ASYMPTOMATIC AT 30 DAY, 6 MONTH, 1 YEAR AND 1.5 YEAR F/U. ONE WEEK POST 1.5 YEAR F/U THE PT SUFFERED A NON Q-WAVE MI LOCATION OF THE INFARCTION WAS NON-DETERMINABLE. REVASCULARIZATION (PTCA) WAS PERFORMED ON THE SAME DAY WITH ONE ENDEAVOR SPRINT RX DRUG ELUTING STENT IMPLANTED TO THE 2ND LEFT POSTEROLATERAL BRANCH. INDICATION FOR INTERVENTION WAS POSITIVE HISTORY OR RECURRENT ANGINA PECTORIS PRESUMABLY RELATED TO THE TARGET VESSEL. INVESTIGATOR INDICATED THAT THE REPORTED EVENT WAS NOT RELATED TO THE STUDY STENT. THE PT WAS TAKING CLOPIDOGREL & ASPIRIN 24 HRS PRIOR TO EVENT. (REF MFR # 9612164201100799 & 9612164201100800).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ENDEAVOR RX SPRINT CORONARY STENT SYSTEM | NIQ | MEDTRONIC IRELAND | NA | 0000539787 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 66 YR | Required Intervention | ASPIRIN 24 HRS PRIOR TO EVENT| CLOPIDOGREL 24 HRS PRIOR TO EVENT |